Cabozat 20mg Tablet is a medication containing Cabozantinib as its active ingredient. Cabozantinib is a tyrosine kinase inhibitor that works by blocking the activity of certain proteins that are involved in cancer cell growth, proliferation, and spread. It targets multiple receptor tyrosine kinases, including MET, VEGFRs, RET, KIT, and AXL, which are often overexpressed or mutated in various cancers. By inhibiting these pathways, Cabozantinib helps to slow down or stop the growth of cancer cells and can also reduce the formation of new blood vessels that tumors need to survive and grow.
Cabozat 20mg Tablet is primarily indicated for the treatment of certain types of cancer, including advanced renal cell carcinoma (kidney cancer) and differentiated thyroid cancer that is metastatic or progressive and refractory to radioactive iodine treatment. It is also used in the treatment of hepatocellular carcinoma (liver cancer) in patients who have previously been treated with sorafenib.
The typical dosage of Cabozat 20mg Tablet is determined by a healthcare professional based on the specific type and stage of cancer being treated, as well as the patient’s individual response and tolerance. It is usually taken orally, with or without food. It is crucial to follow the prescribed dosage and treatment schedule strictly. Common side effects may include diarrhea, fatigue, nausea, vomiting, decreased appetite, hypertension, rash, and hand-foot syndrome. Serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately. Store Cabozat 20mg Tablet at room temperature, away from moisture and heat.
